GenMont Biotech Inc.: Q1 2026 EPS of NT$0.05

Key facts

  • GenMont Biotech Inc.: Q1 2026 EPS of NT$0.05
  • GenMont Biotech Inc. reported an EPS of NT$0.05, operating revenue of NT$89 million, and net profit after tax of NT$2 million for Q1 2026. The company, operating in the biotechnology and medical industry, draws attention to its future growth.
  • Source: PR Times
  • Date: March 1, 2026

Direct answer

GenMont Biotech Inc. reported an EPS of NT$0.05, operating revenue of NT$89 million, and net profit after tax of NT$2 million for Q1 2026. The company, operating in the biotechnology and medical industry, draws attention to its future growth.

Citation
GenMont Biotech Inc.: Q1 2026 EPS of NT$0.05 (March 1, 2026), PR Times
Source
PR Times
Date
March 1, 2026
GenMont Biotech Inc. reported an EPS of NT$0.05, operating revenue of NT$89 million, and net profit after tax of NT$2 million for Q1 2026. The company, operating in the biotechnology and medical industry, draws attention to its future growth.
その他NQ 0/100出典：PR Times

📋 Article Processing Timeline

  • 📰 Published: March 1, 2026 at 09:00
  • 🔍 Collected: May 9, 2026 at 08:00 (1655h 0m after Published)
  • 🤖 AI Analyzed: May 9, 2026 at 08:04 (4 min after Collected)
Company Code: 3164
Company Name: GenMont Biotech Inc.
Industry: Biotechnology and Medical Industry
Year/Quarter: 2026 Q1
Basic Earnings Per Share: NT$0.05
Operating Revenue: NT$89 million
Net Profit After Tax: NT$2 million

FAQ

What are the key facts in this article?

GenMont Biotech Inc. reported an EPS of NT$0.05, operating revenue of NT$89 million, and net profit after tax of NT$2 million for Q1 2026. The company, operating in the biotechnology and medical industry, draws attention to its future growth.

What is the direct answer?

GenMont Biotech Inc. reported an EPS of NT$0.05, operating revenue of NT$89 million, and net profit after tax of NT$2 million for Q1 2026. The company, operating in the biotechnology and medical industry, draws attention to its future growth.

What is the source and date?

PR Times: https://openapi.twse.com.tw/financial/twse-fin-3164-2026Q1 | March 1, 2026

Back to Newsroom (13)